According to Silk Road Medical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.48897. At the end of 2023 the company had a P/S ratio of 2.70.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.70 | -81.44% |
2022 | 14.5 | -0.82% |
2021 | 14.7 | -48.9% |
2020 | 28.7 | 43.93% |
2019 | 19.9 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 1.03 | -77.16% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 92.5 | 1,960.58% | ๐บ๐ธ USA |